← all combinations medical emergency

MDMA + DXM

We recommend avoiding this combination. No numeric safety recommendation possible.

review pending

Content is undergoing medical and legal review. Changes possible.

Substances involved

Risk profile

Both substances act serotonergically and sympathomimetically. DXM also inhibits CYP2D6, which slows MDMA breakdown and raises concentrations. Serotonin syndrome risk, hyperthermia risk.

Acute emergency scenarios

DXM (dextromethorphan, found in cough medicines and used as a recreational substance) is an NMDA antagonist with an additional serotonergic component and strong CYP2D6 inhibition.

Risks in combination with MDMA:

  • Amplified MDMA effect due to slowed breakdown (CYP2D6 inhibition). Even a “normal” MDMA dose can become an effective overdose.
  • Serotonin syndrome risk due to additive serotonergic action
  • Hyperthermia amplified — at higher doses DXM has sympathomimetic effects
  • Dissociative component distorts the perception of heat, so early warning signs get ignored

In polydrug use (e.g. the “robotripping” context) this combination is common, but pharmacologically risky.

We recommend avoiding this combination. If you use it anyway: low single doses of both substances, clear breaks, and when in doubt only one substance.

Some “cough suppressants” contain DXM — if you have a cold during an MDMA phase, check the labels carefully.